This inventor holds 4 USPTO granted patents and 9 published patent applications. Top assignees: Beijing Solobio Genetechnology Co., Ltd., Staidson (Beijing) Biopharmaceuticals Co., Ltd, Staidson (Beijing) Biopharmaceuticals Co., Ltd.. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025-2026
Title: Innovations of Zhong Li in Biopharmaceuticals
Introduction
Zhong Li is a prominent inventor based in Beijing, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibodies. His work focuses on innovative solutions that address critical health challenges.
Latest Patents
Zhong Li holds a patent for "Antibodies specifically recognizing PcrV and uses thereof." This patent includes antibodies, including antigen-binding fragments, that specifically recognize PcrV. Additionally, it provides methods for making and using these antibodies, showcasing his expertise in biopharmaceutical research.
Career Highlights
Zhong Li is associated with Staidson (Beijing) Biopharmaceuticals Co., Ltd., where he applies his knowledge and skills to advance the company's research initiatives. His work has been instrumental in developing new therapeutic options that can improve patient outcomes.
Collaborations
Zhong Li collaborates with notable colleagues, including Maorong Yu and Chao Wang. Their combined efforts contribute to the innovative research environment at Staidson, fostering advancements in biopharmaceuticals.
Conclusion
Zhong Li's contributions to the field of biopharmaceuticals through his patent and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for new therapeutic developments that can benefit society.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile